ASO Author Reflections: The Gustave Roussy Immune Score May Be a Useful Biomarker for Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Gastric Cancer
Crossref DOI link: https://doi.org/10.1245/s10434-024-16238-0
Published Online: 2024-09-17
Published Print: 2024-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nakazawa, Nobuhiro
Sano, Akihiko
Sakai, Makoto
Shirabe, Ken
Saeki, Hiroshi
Text and Data Mining valid from 2024-09-17
Version of Record valid from 2024-09-17
Article History
Received: 3 September 2024
Accepted: 4 September 2024
First Online: 17 September 2024
Disclosures
: The authors report no conflicts of interest.